Larkspur Bioscience at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Larkspur Bioscience takes part in 2 sessions at TPD Summit 2026 in Boston. Its sessions cover its PIP4K2C degrader LRK-4189 as it enters the clinic for microsatellite-stable colorectal cancer, and the wider trends shaping induced proximity.

OrganizationTPD Summit 2026 Attendance
larkspur.bio
Biotech
Develops targeted protein degraders that disrupt cancer cell fitness, including the PIP4K2C degrader LRK-4189.
Panel
Tue Oct 27
9:00am
Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact
Plenary · with Nurix Therapeutics, Foghorn Therapeutics, Stablix +1 more
Investment, partnering & strategy
Talk
Tue Oct 27
11:30am
Targeting Cancer Fitness: PIP4K2C Degrader LRK-4189 Enters the Clinic for MSS CRC & Beyond
Track C: Translational & Clinical Development

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Larkspur Bioscience

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction